DLX2
Basic information
Region (hg38): 2:172099438-172102900
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DLX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 1 | 2 |
Variants in DLX2
This is a list of pathogenic ClinVar variants found in the DLX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-172100575-C-G | not specified | Uncertain significance (Aug 20, 2024) | ||
2-172100586-T-C | not specified | Uncertain significance (Sep 26, 2024) | ||
2-172100638-G-T | not specified | Uncertain significance (Dec 02, 2021) | ||
2-172100639-C-A | Likely benign (Aug 08, 2018) | |||
2-172100650-G-T | not specified | Uncertain significance (Jul 12, 2023) | ||
2-172100658-G-A | not specified | Uncertain significance (Mar 25, 2022) | ||
2-172100668-C-T | not specified | Uncertain significance (Nov 13, 2024) | ||
2-172100677-G-C | not specified | Uncertain significance (Aug 05, 2024) | ||
2-172100682-T-A | not specified | Uncertain significance (Apr 09, 2024) | ||
2-172100737-A-C | not specified | Uncertain significance (Nov 29, 2021) | ||
2-172100743-C-A | not specified | Uncertain significance (Feb 12, 2024) | ||
2-172100743-C-G | not specified | Uncertain significance (Jan 23, 2023) | ||
2-172100759-A-T | not specified | Uncertain significance (May 31, 2023) | ||
2-172100790-T-G | not specified | Uncertain significance (Nov 13, 2023) | ||
2-172100793-G-T | not specified | Uncertain significance (Sep 27, 2024) | ||
2-172100815-C-T | not specified | Uncertain significance (Jul 26, 2024) | ||
2-172100830-G-C | not specified | Uncertain significance (Jul 20, 2021) | ||
2-172100880-G-A | not specified | Uncertain significance (Nov 10, 2024) | ||
2-172100890-C-T | not specified | Uncertain significance (May 18, 2022) | ||
2-172101479-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
2-172101552-C-A | Benign (May 03, 2018) | |||
2-172101593-C-T | not specified | Uncertain significance (Jan 17, 2023) | ||
2-172101608-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
2-172102261-T-C | not specified | Uncertain significance (Oct 08, 2024) | ||
2-172102267-T-A | not specified | Uncertain significance (Oct 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DLX2 | protein_coding | protein_coding | ENST00000234198 | 3 | 3462 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.978 | 0.0215 | 125703 | 0 | 2 | 125705 | 0.00000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.949 | 141 | 176 | 0.799 | 0.00000799 | 2090 |
Missense in Polyphen | 26 | 47.467 | 0.54775 | 517 | ||
Synonymous | 0.281 | 76 | 79.2 | 0.960 | 0.00000382 | 683 |
Loss of Function | 3.18 | 0 | 11.8 | 0.00 | 5.02e-7 | 129 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000880 | 0.00000880 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional activator. Plays a role in terminal differentiation of interneurons, such as amacrine and bipolar cells in the developing retina. Likely to play a regulatory role in the development of the ventral forebrain. May play a role in craniofacial patterning and morphogenesis. {ECO:0000250|UniProtKB:P40764}.;
- Pathway
- Preimplantation Embryo;Olfactory bulb development and olfactory learning;Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.189
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.25
Haploinsufficiency Scores
- pHI
- 0.895
- hipred
- Y
- hipred_score
- 0.806
- ghis
- 0.550
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.987
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dlx2
- Phenotype
- respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; digestive/alimentary phenotype; skeleton phenotype; growth/size/body region phenotype; muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- dlx2a
- Affected structure
- ceratobranchial cartilage
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;brain development;proximal/distal pattern formation;subpallium development;hippocampus development;olfactory bulb development;regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment;cerebral cortex GABAergic interneuron fate commitment;cell differentiation;odontogenesis of dentin-containing tooth;positive regulation of cell differentiation;negative regulation of Notch signaling pathway;positive regulation of transcription by RNA polymerase II;negative regulation of photoreceptor cell differentiation;embryonic cranial skeleton morphogenesis;negative regulation of oligodendrocyte differentiation;branching morphogenesis of a nerve;cartilage development;positive regulation of amacrine cell differentiation
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;DNA-binding transcription factor activity;single-stranded RNA binding;protein binding;sequence-specific DNA binding